PRDX5 and Ewing sarcoma: In addition, the sensitivity of Ewing sarcoma cell lines to auranofin was dependent on the expression of the EWS-FLI1 oncoprotein, which suggests that thioredoxin reductase may target a unique vulnerability in Ewing sarcoma tumors (23).